IRA & Medicare drug price negotiation
Medicare Drug Plans Are Hiking Premiums While Trump Claims Victory on Medicine Prices
KFF Health NewsTopic alignment 85
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase by switching to lower-cost plans.
Filed under
CMS Issues Final Rule on the Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program
AMCP (Academy of Managed Care Pharmacy)Topic alignment 95
CMS finalizes rule to codify Medicare Drug Price Negotiation Program
AHATopic alignment 95
Most-Favored-Nation Drug Pricing Framework: How Manufacturer Agreements Affect Medicaid Best Price, Contracts, and Compliance
Frier LevittTopic alignment 90
How the Biosimilars Access and Affordability Act Redefines IRA Delays
The Center for BiosimilarsTopic alignment 92